abstral 200 mikrog resoribletti
kyowa kirin holdings b.v. - fentanyl citrate - resoribletti - 200 mikrog - fentanyyli
abstral 300 mikrog resoribletti
kyowa kirin holdings b.v. - fentanyl citrate - resoribletti - 300 mikrog - fentanyyli
abstral 400 mikrog resoribletti
kyowa kirin holdings b.v. - fentanyl citrate - resoribletti - 400 mikrog - fentanyyli
abstral 600 mikrog resoribletti
kyowa kirin holdings b.v. - fentanyl citrate - resoribletti - 600 mikrog - fentanyyli
abstral 800 mikrog resoribletti
kyowa kirin holdings b.v. - fentanyl citrate - resoribletti - 800 mikrog - fentanyyli
xyrem 500 mg/ml oraaliliuos
ucb pharma ltd - natrium oxybas - oraaliliuos - 500 mg/ml - natriumoksibaatti
rativor 2.5 mg tabletti
macure healthcare limited - lorazepam - tabletti - 2.5 mg - loratsepaami
rativor 1 mg tabletti
macure healthcare limited - lorazepam - tabletti - 1 mg - loratsepaami
rativor 0.5 mg tabletti
macure healthcare limited - lorazepam - tabletti - 0.5 mg - loratsepaami
wakix
bioprojet pharma - pitolisant - narkolepsia - muut hermoston huumeet - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.